Skip to main content
Caplight Logo









Tesarakt

Tesarakt

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://tesarakt.com

Last Round

Pre Seed

Jul 1, 2022

Total Funding Raised

$500,000

Company Overview

Tesarakt operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a Pre Seed round in July 2022.

Tesarakt is a biotechnology research company that develops predictive artificial intelligence and big data solutions for the early diagnosis of neurological disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Tesarakt Comparables

Compare Tesarakt with similar companies based on industry and business-model similarity.

Tesarakt comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Darmiyan
85%
NeuroXT
84%
In-Med Prognostics
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Tesarakt Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedJul 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Tesarakt Investors

Notable investors and investment history

Tesarakt investors
InvestorRounds
IndieBioPre Seed
SOSVPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 1, 2022

    $500K round with SOSV and IndieBio

Book a demo to see all signals

For institutional investors. Book with your work email.

Tesarakt Filings

Explore SEC and related filing metadata, where available.

Tesarakt filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Tesarakt's valuation, stock price, and market status.

Is Tesarakt a public or private company?

Tesarakt is a private company.

What is the current stock price of Tesarakt?

Tesarakt is a private company, so its shares have no public market price. Caplight tracks Tesarakt's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Tesarakt worth (valuation)?

Valuation information for Tesarakt is not publicly available.

Can I buy Tesarakt stock?

Tesarakt shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Tesarakt's last funding round?

Tesarakt's most recent funding round was Pre Seed on July 1, 2022.

Who are the main investors in Tesarakt?

Key investors in Tesarakt include IndieBio, SOSV.

Will Tesarakt IPO soon?

No public IPO plans have been announced for Tesarakt.

How can I track Tesarakt secondary market activity?

Caplight tracks bids, offers, and trades in Tesarakt's shares on secondary markets.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range1
Year Founded2022
Last FundingJul 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?